A B S T R A C T Chromatographic, ultracentrifugal, and related studies of the fibrinogen of a patient with a congenital disorder of fibrinogen (fibrinogen "Baltimore") have provided evidence of structural differences from normal.
Diethylaminoethyl-cellulose (DEAE-cellulose) gradient elution chromatography demonstrated two major peaks in the elution pattern of fibrinogen Baltimore as was the case for normal fibrinogen. However, the first peak of fibrinogen Baltimore was somewhat broader and more symmetrical and was eluted significantly later in the chromatogram than the corresponding peak of normal fibrinogen. Additionally, in some elution patterns, a shoulder on the ascending limb of peak 1 was present, suggesting the presence of chromatographically "normal" fibrinogen. Thrombin time determinations of eluted column fractions from a chromatogram of propositus fibrinogen supported this conclusion by demonstrating that fibrinogen from the ascending portion of peak 1 behaved functionally more like normal than that later in the chromatogram. Chromatograms of mixtures of propositus and normal fibrinogen confirmed the ability of this technique to distinguish normal from Baltimore fibrinogen. Chromatograms of fibrinogen isolated from two affected daughters displayed the characteristic increased anionic binding of peak 1 fibrinogen.
Sedimentation velocity experiments indicated that the S020,W of fibrinogen Baltimore was slightly greater (8.13S vs. 7.85S) than that of normal fraction I-4. Differences in concentration dependence (-0.65 c vs. (1) reported the results of studies on the blood of a young woman with a history of recurrent thrombosis, pulmonary embolism, and mild bleeding tendency. The rate of coagulation of her plasma by thrombin or reptilase was delayed markedly although the amount of fibrinogen detectable by immunochemical techniques was normal (2) . Thrombin clots formed from recalcified plasma were insoluble in 5 M urea. There was no evidence of increased fibrinolysis or fibrinogen turnover. Immunoelectrophoretic studies suggested slightly greater anodal mobility of patient plasma fibrinogen compared with that of normal (3) . On the basis of this evidence and associated family studies demonstrating the abnormality in three successive generations, it was proposed that this kindred was another example of a functionally defective fibrinogen such as had already been described by Imperato and Dettori (4) and Menache (5) . Employing a nomenclature similar to that for hemoglobinopathies the abnormal fibrinogen was designated fibrinogen "Baltimore." Since that time several other kindred have been recognized with abnormally slowly clotting fibrinogen (6) (7) (8) (9) (10) (11) (12) ; evidence of amino acid substitution (serine for arginine) has been demonstrated in the N-terminal portion of the a(A)-chain of fibrinogen Detroit (13) . Similar studies of fibrinogen Baltimore have failed to demonstrate any abnormality of that portion of the molecule.'
In this report the results of investigations relating to the characterization of fibrinogen Baltimore by gradient elution chromatography, and ultracentrifugal and related techniques are presented.
METHODS
Single donor and propositus fibrinogen was prepared from citrated or acid, citrate, dextrose (ACD) plasma. It is noteworthy that of the total plasma fibrinogen measured in five samples of propositus plasma by the method of Ratnoff and Menzie (14) (mean = 141 mg/100 ml; range = approximately 22% (range = 20-25) remained in the supernatant of fraction I, a finding similar to that for normal plasma fibrinogen (15) . Patient or normal material equivalent in solubility to fraction I-2 was prepared by the method of Blomback and Blombick (16) or by the procedure of Laki (17) from fraction I. Certain preparations were reprecipitated with 2.1 M glycine (18) to increase clottability (usually to 94% or more). Alternatively, the procedure described by Mosesson and Sherry (15) was employed. Fibrinogen for chromatography from two affected daughters of the propositus was prepared from relatively small amounts (9-10 ml) of plasma by 2.1 M glycine reprecipitation of Cohn fraction I. The clottability of each sample was about 70%. Normal human fraction 1-4 (more than 97% clottable) was prepared from pooled outdated ACD plasma (15, 16) . Only material of 94%o or more clottability was used for ultracentrifugal and other quantitative analytical procedures performed on propositus fibrinogen.
Clottability was determined by the spectrophotometric procedure of Laki (17) modified in that the clots were incubated at 2°-5aC for at least 18 hr before analysis.
Thrombin time determinations were carried out at 370C by adding 0.05 ml of thrombin solution (approximately 5 U. S. Standard U/ml) in phosphate-buffered saline (0.15 M NaCl, 0.01 M sodium phosphate, pH 7.0) to a 0.05-ml sample which had been dialyzed against phosphate-buffered saline. The thrombin was bovine thrombin (Parke, Davis & Co.) stored as a stock solution of 200 U. S. Standard U/ml in 50%o glycerol at 50C and diluted for use. End points were determined with the aid of a Nichrome wire loop. Timing of end points was not carried beyond 120 sec. For normal fibrinogen the earliest evidence of clot formation (i.e. a single small fibrin strand) was followed very closely by evidence of definite fibrin formation (i.e. firm clot or thick strand adhering to wire loop). In the case of fibrinogen Baltimore samples, particularly at the concentrations studied (vide infra), evidence of definite fibrin formation often lagged far behind the earliest evidence of clot formation. Because of the possibility that early evidence of clot formation indicated the presence of "normal" fibrinogen in fibrinogen Baltimore samples, whereas delayed formation of a firm fibrin clot reflected the presence of fibrinogen Baltimore itself, two end points were recorded for all samples analyzed in this manner (e.g. Table I ).
Column chromatography on DEAE-cellulose was performed at 3°-50C using a continuous concave Tris-phosphate salt and pH gradient from 0.005 M phosphate (pH 8.6) to 0.50 M phosphate (pH 4.1-4.3) as described for the chromatography of fibrinogen (19) modified for examination of small samples (20) . Acrylamide-gel electrophoresis was carried out as previously outlined (20) .
Eluted column fractions for thrombin time determinations were pooled, precipitated with 1/3 saturated ammonium sulfate, and redissolved in saline; further reduction in volume was accomplished by pervaporation before dialysis against phosphate-buffered saline, pH 7.0. Protein concentration of individual samples was estimated spectrophotometrically assuming AM'1 cm at 280 my = 15. Owing to the small amounts Fibrinogen BaltimoreTUBE NUMBER FIGURE 1 DEAE-cellulose gradient chromatographic pattern of 22 mg of fibrinogen Baltimore (I-2) compared with 28 mg of normal fibrinogen (I-4). Each was chromatographed separately under identical conditions. The molarity of the theoretical phosphate gradient is illustrated by the dashed line.
of material recovered in the precipitated column fractions the thrombin time assay was carried out within the range 0.53-0.87 mg/ml protein. Thrombin time determination of normal fibrinogen within this concentration range indicated that the end point was relatively independent of concentration (about 1 sec difference at the extremes of concentration).
Ultracentrifugation of purified, dialyzed fibrinogen fractions was performed in a Spinco Model E analytical ultracentrifuge using schlieren optics. Concentration was determined with a Brice-Phoenix differential refractometer, assuming a specific refractive increment of 0.188 ml/g at 546 mA (21) . Tyrosine/tryptophan ratios were calculated by the method of Bencze and Schmid (22) .
Hexose analysis was performed by the orcinol method as described by Winzler (23) using a 1: 1 galactose-mannose standard. Sialic acid content was determined by the thiobarbituric acid method (24) and calculated as N-acetyl neuraminic acid. N-terminal amino acid analysis was performed by the dinitrofluorobenzene (DNFB) method as described by Fraenkel-Conrat, Harris, and Levy (25) . Thinlayer chromatography of dinitrophenyl (DNP) amino acids was performed on 20 X 20 cm glass plates coated with Silica Gel G' using the toluene: 2-chlorethanol: pyridine: 0.8 N ammonium hydroxide (30:18: 9: 18) solvent for the first dimension and chloroform: methanol: acetic acid (95: 5: 1) for the second (26) .
RESULTS
Gradient chromatography of propositus fibrinogen (8 chromatograms of five preparations) on DEAE-cellulose (including one chromatogram each of propositus fraction I and I-1) demonstrated small but consistent differences between patient and normal fibrinogen (Fig.  1) . As is the case with normal fibrinogen (19, 20) symmetrical and peaked later (mean = tube 42; range = tube 38-45) than its presumed normal counterpart. The difference in the position of the peak from normal was statistically significant at P < 0.001. The onset of elution of the first peak of fibrinogen Baltimore samples tended to occur up to five tubes later than that of normal fibrinogen samples but this phenomenon was more variable than the position of the peak tube itself. In some preparations (three of five), as illustrated by Fig. 1 , the ascending limb of peak 1 had a shoulder, suggesting that there were at least two components to the peak. The second peak was eluted in approximately the same position as peak 2 of normal fibrinogen but was usually broader and less well defined, making it difficult to determine its precise location. Chromatographic analyses of the partially purified fibrinogen of two affected daughters of the propositus demonstrated (Fig. 2 ) the increased anionic binding of peak 1 characteristic of the propositus' fibrinogen. However, the small amount of material studied did not permit any additional meaningful conclusions from these data.
To further explore the nature of the ascending limb of propositus peak 1, mixtures of propositus (P) and normal (N) fibrinogen were chromatographed (Fig. 3) . ' Single donor fibrinogen prepared from plasma obtained from 21 normal individuals, two patients with hemophilia A, and two patients with von Willebrand's disease were used for comparison. Chromatograms of these 25 preparations of normal fibrinogen (8-36 mg) revealed the peak of the first chromatographic type between tubes 32 and 37 (mean = 34 +2), and that of the second chromatographic type between tubes 53 and 65 (mean= 60 3).
The elution profile of propositus fibrinogen (100%, P) again demonstrated the increased anionic binding capacity characteristic of peak 1. The ascending limb of peak 1 in this instance appeared smooth, and peak 2 was well defined. The elution profile of a mixture consisting predominantly of propositus fibrinogen (87%, P; 13%, N) was somewhat different, most notable being the appearance of a small 'shoulder" on the ascending limb of peak 1. The elution profile of a mixture which was predominantly normal fibrinogen (7%, P; 93%, N) was virtually indistinguishable from the normal (100% N). A chromatogram of a mixture of approximately equal amounts of propositus and normal fibrinogen (55%, P; 45% N) displayed an elution profile with features of both fibrinogens, particularly in the appearance of peak 1 which was broader than either the normal or abnormal The results of thrombin time determinations on each of the concentrated, dialyzed fractions and related sam-'There was insufficient fibrinogen recovered from the ascending limb of peak 1 to permit thrombin time determination of this fraction; therefore, peak 1 fractions were pooled (i.e. "chromatographic peak 1," Table I ). However, in a subsequent chromatographic experiment on normal fraction I-2, sufficient material was recovered from pooled, subfractions of peak 1 to allow comparative thrombin time determinations to be carried out. The mean (first end point) of replicate thrombin time determinations (protein concentration in parentheses) of starting fraction I-2 (0.73 mg/ml), ascending limb (0.54 mg/ml), peak (0.58 mg/ml), and descending limb (0.87 mg/ml) of chromatographic peak 1 were 122, 13.6, 13.6, and 12.3 sec, respectively. These values were not significantly different from one another nor were the second end points, which occurred within 1 sec of the first in every instance. Fibrinogen Baltimore ples (Table I) indicated that the thrombin time of the fraction obtained from the ascending limb of propositus peak 1 was shorter than that of the peak or of the descending limb, and approached that of normal fibrinogen.
Analytical ultracentrifugation of the propositus' fibrinogen (94% clottable) demonstrated a single symmetrical peak sedimenting at a slightly higher s2o.
(8.13 vs. 7.85 s) than that of normal fibrinogen (Fig. 4) . There were differences in the concentration dependence (sao.w vs. concentration) of propositus fibrinogen (-0.65 c) compared with that of normal (-1.30 c) .
Under appropriate conditions, human fibrinogen fractions of differing molecular weights can be distinguished by the molecular sieving properties of acrylamide gels (20) . The patterns of propositus fibrinogen and normal fraction I-4 (mol wt = 325,000) electrophoresed at two gel concentrations (8 and 10%) were virtually indistinguishable.' In contrast, low molecular weight human fibrinogen (fraction I-8, mol wt = 270,000) was easily distinguished from fraction I-4 under these conditions; these observations supported the notion that the molecular weight of fibrinogen Baltimore does not differ significantly from that of classically prepared normal fibrinogen (i.e. fraction I-4).
The UV spectrum (245-360 mu) of propositus fibrinogen in 5 M urea and 0.1 M NaOH was indistinguishable from normal. Further analysis of these curves (22) indicated that there were no significant differences in tyrosine/tryptophan ratios (1.34:1 vs. 1.32:1 for normal). Differences in the absorbancy coefficient (A 1 %) at 282 myA in alkaline urea were marginal (16.2 vs. 16.7 for normal). There were no consistent significant differences in sialic acid and hexose content.
N-terminal amino acid analysis was undertaken on an amount of material sufficient only for qualitative analysis (approximately 8 mg). The results of this analysis demonstrated the presence of alanine and tyrosine, which are known to be the major amino terminals of normal human fibrinogen. Smaller amounts of other amino acids (e.g. aspartic acid) could not have been detected with the amount of material analyzed.
DISCUSSION
Ultracentrifugal studies indicated a small difference in the s°2o,. of propositus fibrinogen as compared with normal. The differences in the concentration dependence of the sedimentation coefficient might be partially explicable by the somewhat different ionic strength (see legend Fig. 4 ) of the solutions in which the two fibrinogens were studied (27) . However, the difference was greater than could be accounted for on the basis of salt concentration alone; the possibility of a spatial conformational difference (28) was also raised by these data. A positive slope for fibrinogen prepared from certain patients with hemophilia A has been described and attributed to a tendency for molecular aggregation at higher concentrations (29) .
Results of molecular sieving experiments in acrylamide gels suggested that the molecular weight of apparently two more or less widely separate thrombin time end points for propositus fibrinogen samples (i.e. first evidence of clot formation and evidence of definite fibrin formation) compared with normal fibrinogen raised the possibility that the early end point might indicate the presence of "normal" fibrinogen present in propositus samples. From chromatographic mixing experiments (Fig. 3) it was apparent that normal and propositus peak 1 fibrinogen were distinguishable although not separable from one another. It could be estimated that the apparent content of "normal" fibrinogen present in the propositus preparation represented by Fig. 1 was approximately 15-25% . The usefulness of the chromatographic method in these studies as a convenient means of recognition and semiquantitation of normal fibrinogen in the presence of abnormal was obvious. This technique has also proven of value' in differentiating fibrinogen Paris (5) from normal. On the other hand, Sherman, Gaston, and Spivak (12) could demonstrate no chromatographic abnormalities in the fibrinogen of their patient.
The presence of mixtures of normal and abnormal fibrinogen have been suggested by immunoelectrophoretic studies in the case of fibrinogen Cleveland (9) and fibrinogen Detroit (8) and are consistent with the autosomal inheritance pattern postulated for both kindreds. Paradoxically, however, Blombick et al. (13) in their sequence studies of fibrinogen Detroit found a total absence of the normal a(A)-peptide chain. With regard to the results of recent similar studies on fibrinogen Baltimore in which no abnormalities of the a(A)-chain have yet been found,' the possibility that the presence of contaminating amounts of normal fibrinogen might complicate the discovery of an abnormal peptide sequence should be considered.
ADDENDUM
Since this manuscript was accepted for publication von Felten, Frick, and Straub (31) have provided evidence, based mainly upon the study of polymerization of fibrin derived from reptilase-treated plasma, for the copresence of functionally normal and abnormal fibrinogen in the plasma of their patient (fibrinogen Zurich) (7). This finding is consistent with the autosomal inheritance pattern suggested from previous studies (7) .
